Estrogen replacement therapy i: A 10-year prospective study in the relationship to osteoporosis

Obstetrics and Gynecology

Volumn 53, Issue 3, 1979, Pages 277-281

  Nachtigall, Lila E ^a   Nachtigall, Richard H ^a   Nachtigall, Robert D ^a   Mark Beckman, E ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

BONE; DRUG THERAPY; ENDOCRINE SYSTEM; FEMALE GENITAL SYSTEM; MENOPAUSE; OSTEOPOROSIS; THERAPY;

CLINICAL TRIALS; DOUBLE-BLIND METHOD; ESTROGENS, CONJUGATED; FEMALE; HUMAN; MEDROXYPROGESTERONE; MENOPAUSE; OSTEOPOROSIS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0018345196     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Nachtigall LE, Nachtigall RH, Nachtigall RD, et al: Estrogen replacement therapy. II. A 10-year prospective study in the relationship to carcinoma, cardiovascular, and metabolic problems. Obstet Gynecol (In press)
2. Cameron JR, Sorenson J: Measurement of bone mineral in vivo. Science 142:230, 1963
3. Kerlinger F, Pedhauzr E: Multiple Regression in Behavioral Research. New York, Holt, Rhinehart and Winston, 1973
4. Wilson RA: Feminine Forever. New York, M. Evans, 1966
5. Mack TM, Pike MC, Henderson BE, et al: Estrogens and endometrial carcinoma in a retirement community. N Engl J Med 294:1262, 1976
6. Smith DC, Prentice R, Thompson DJ, et al: Association of exogenous estrogen and endoemtrial carcinoma. N Engl J Med 293:1164, 1975
7. Weiss NS, Szekely DR, Austin DF: Increasing incidence of endometrial cancer in the United States. N Engl J Med 294:1259, 1976
8. Zeil HK, Finkle WD: Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 293:1167, 1975
9. Ryan KJ: Editiorial: Cancer risk and estrogen use in the menopause. N Engl J Med 243:1199, 1975
10. Wheeler M: Osteoporosis. Med Clin North Am 60:1213, 1976
11. Heany RP: Estrogens and post menopausal osteoporosis. Clin Obstet Gynecol 19:791, 1976
12. Alffram P-A: An epidemiologic study of cervical and trochanteric fractures of the femur in an urban population. Acta Or-thop Scan (Suppl) 65:9, 1964
13. Albright F, et al: Postmenopausal osteoporosis. JAMA 116:2465, 1941
14. Smith DA, et al: Changes in metacarpal mineral content and density in normal male and female subjects with age. Clin Radiol 20:23, 1969
15. Nordin BCE: Clinical significance and pathogenesis of osteoporosis. Br Med J 1:571, 1971
16. Meema S, et al: Preventive effect of estrogen loss on postmenopausal bone loss. Arch Intern Med 135:1436, 1975
17. Meema HE, Meema S: Prevention of postmenopausal osteoporosis by hormonal treatment of the menopause. Can Med Assoc J 99:248, 1968
18. Riggs BL, Jowsey J, Goldsmith RS, et al: Short-and long-term effects of estrogen and synthetic anabolic hormone in post menopausal osteoporosis. J Clin Invest 1:1659, 1972
19. Schindler AE, Ebert A, Friedrich E: Conversion of andro-stenedione to estrone by human fat tissue. J Clin Endocrinol Metab 35:627, 1972
20. Kuhlencordt F: Osteoporosis-Etiology, pathogenesis, diagnosis and treatment. Calcif Tissue Res (Suppl) 21:405, 1976
21. Danieli HW: Osteoporosis of the slender smoker. Arch Intern Med 136:298, 1976
22. Edinburgh JC, Hong Kong KC. Ho: Geographical variations in senile osteoporosis. J Bone Joint Surg 52(Br):667, 1970
23. Doyle F, et al: Relationship between bone mass and muscle weight. Lancet 1:391, 1970
24. Aiken DA, Speirs CF: Osteoporosis after oophorectomy for non-malignant disease in premenopausal women. Br Med J 2:325, 1973
25. Garn SM, Rahmanu CF, Wagner B: Bone loss as a general phenomenon in man. Fed Proc 26:1729, 1967
26. Davis ME, Stranajord N, Lange LH: Estrogen and the aging process. JAMA 196:219, 1966